Table 4.
Tracer | Chemical structure | Approval year | |||||
---|---|---|---|---|---|---|---|
FDA | Europe | Japan | |||||
Sympathetic nervous system | |||||||
Presynaptic | |||||||
Catecholamine derivative | 123I-MIBG | 2008 | 1995** | 1992 | |||
11C-hydroxyephedrine | – | – | – | ||||
18F-LMI1195 | – | – | – | ||||
18F-4-fluorometaraminol (4-[18F]fluorometaraminol) |
– | – | – | ||||
Catecholamine | 18F-fluorodopamine | – | – | – | |||
11C-epinephrine | – | – | – | ||||
11C-phenylephrine | – | – | – | ||||
Postsynaptic | |||||||
α-receptor | 11C-prazosin | – | – | – | |||
β-receptor | 11C-CGP12177 | – | – | – | |||
11C-CGP12388 | – | – | – | ||||
18F-fluorocarazolol | – | – | – | ||||
Parasympathetic nervous system | |||||||
Presynaptic | Vesicular acetylcholine transporter | 18F-fluoroethoxybenzovesamicol | – | – | – | ||
Postsynaptic | Muscarine | 11C-methyl QNB | – | – | – | ||
11C-methyl TRB | – | – | – |
**EURD list nov 2012 http://www.ema.europa.eu/docs/en_GB/document_library/Other/2012/04/WC500124999.xls